Kevin Judice serves as Executive at DICE Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Kevin Judice has executed 2 insider transactions totaling $500.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 9, 2023 involved selling 799,685 shares valued at $0.
Kevin Judice currently holds 799,685 shares of DICE Therapeutics, Inc. (DICE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kevin Judice has been a net seller of DICE stock. They have purchased $0 and sold $500.0K worth of shares.
Kevin Judice's most recent insider trade was on Aug 9, 2023, when they sold 799,685 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $36.50 |
| Discretionary |